The FBRI VTC Neuromotor Research Clinic

October 17, 2023 updated by: Stephanie DeLuca, Virginia Polytechnic Institute and State University

The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy.

ACQUIREc Therapy is an evidenced-based approach to pediatric constraint-induced movement therapy, which refers to a multi-component form of therapy that is focused on helping children who have asymmetric motor abilities between the two sides of the body. Historically, ACQUIREc Therapy has the unimpaired or less impaired upper extremity constrained (by a cast or a splint) while also receiving active therapy from a specially trained therapist who shapes new skills and functional activities with the child's more impaired upper extremity but who is also a licensed Occupational or Physical Therapist (OT/PT). Therapy dosages are high much higher than tradition OT or PT - often lasting many hours per day, up to 6 hours a day, 5 days a week, for 2-4 weeks.

Investigators have developed further treatments based on the same principles of intensive services combined with behavior shaping for other areas of the body that are also affected by weakness (e.g., the leg and trunk) also, but which usually do not involve constraint. These have been more generally labeled ACQUIRE Therapy.

All forms involve intensive, play-based therapy for children with asymmetric motor impairments of the arms and hands. The primary focus of treatment is to facilitate the acquisition of new motor skills in the child's weaker body parts through high levels of intensive therapy using scientifically-based behavioral guidelines. Therapy is also delivered in naturalistic environments.

ACQUIREc Therapy as a treatment method has been tested in two randomized controlled trials, and a specific manual for its implementation has been developed. Dr. (s) Ramey and DeLuca previously founded a similar clinic, The Pediatric Neuromotor Research Clinic, at the University of Alabama at Birmingham where Dr. DeLuca directed the research clinic for 13 years and oversaw the implementation of the ACQUIREc Therapy treatment protocol in more than 400 cases.

This research will involve analyzing and interpreting the clinical data of children going through clinical procedures at the FBRI VTC Neuromotor Research Clinic. All participation is voluntary and no children will denied services if families choose not to participate.

Study Overview

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Virginia
      • Roanoke, Virginia, United States, 24016
        • Recruiting
        • Fralin Biomedical Research Institute - VTC
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 18 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Individuals with neuromotor impairment who want to try and gain motor skills and function

Description

Inclusion Criteria:

  • Neuromotor Impairment

Exclusion Criteria:

  • fragile health

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children and Adults with Cerebral Palsy
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
Children and Adults with Microcephaly
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
Children and Adults with other Neuromotor Impairments
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs
Children who have had a stroke
Intensive therapy services combined with operant conditioning during treatment delivered by trained OT or PTs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emerging Behaviors Scale
Time Frame: up to 12 months
This is a measure of the number of skills a child uses from a set of 31 typical used on a daily basis
up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assisting Hand Assessment
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
This is a measure of bimanual arm and hand use
Within 1 week prior to treatment and Within 1 week after treatment
Pediatric Motor Activity Log
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
This is a parental report about a child's ability to use an impaired arm and hand on a daily basis
Within 1 week prior to treatment and Within 1 week after treatment
Peabody Developmental Motor Scales 2
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
This is a measure of a child's motor abilities in comparison to typical development
Within 1 week prior to treatment and Within 1 week after treatment
The Bayley Motor Scales of Infant Development -III
Time Frame: Within 1 week prior to treatment and Within 1 week after treatment
This is a measure of a infants's motor abilities in comparison to typical development
Within 1 week prior to treatment and Within 1 week after treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Video Assessments
Time Frame: Within 1 week prior to treatment, during treatment, and Within 1 week after treatment
Videos of play and therapy sessions
Within 1 week prior to treatment, during treatment, and Within 1 week after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie DeLuca, PhD, Virginia Polytechnic Institute and State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2013

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

October 9, 2017

First Submitted That Met QC Criteria

October 27, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

October 18, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data is released only with participant (parental/ guardian) permission

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on ACQUIRE Therapy

3
Subscribe